FXN predicts poor prognosis in colon adenocarcinoma and correlates with immune cell infiltration
Mengya Sun, Qizhong Shi, Yonghui Mu, Chenglei Li, Wenchao Zhao, Na Han · 2026
Read FXN predicts poor prognosis in colon adenocarcinoma and correlates with immune cell infiltration by Mengya Sun, Qizhong Shi, Yonghui Mu, Chenglei Li, Wenchao Zhao, Na Han (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13601114.txt.
Description
Mengya Sun and co-authors studied frataxin, a mitochondrial protein, as a warning sign in colon adenocarcinoma in 2026. The protein takes part in many cell processes, but its role in this common colon cancer was unclear. The team asked whether its level in tumors tracks patient outlook and immune cell presence.
They measured the protein in tumor data through bioinformatics and confirmed it with tissue staining. Survival methods linked high levels to prognosis, and enrichment analysis hinted at the biology behind the link. Lab assays then tested how the protein affects cancer cell growth, spread, and invasion. Gene-based scores related its level to immune cells in the tumor. Readers get a candidate marker that is both a warning sign and a possible driver worth targeting.
Catalog record
| CREATOR | Mengya Sun, Qizhong Shi, Yonghui Mu, Chenglei Li, Wenchao Zhao, Na Han |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |